Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
Savolitinib and osimertinib combination significantly improves PFS in EGFR-mutated NSCLC with MET amplification compared to ...
The final, formatted version of the article will be published soon. Background: Germ-line EGFR mutations are rare, and their clinical significance, particularly regarding response to tyrosine kinase ...
The final, formatted version of the article will be published soon. Objectives: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are established first-line treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback